- Novavax Inc said on Tuesday its experimental COVID-19 vaccine produced high levels of antibodies against the novel coronavirus, according to initial data from a small, early-stage clinical trial, sending the company’s shares up 10%.
Maryland-based Novavax said its vaccine candidate, NVX-CoV2373, produced higher levels of the antibodies in healthy volunteers after two doses than those found in recovered COVID-19 patients, raising hopes for its eventual success. Effective vaccines and treatments are considered essential to halting a pandemic that has claimed more than 695,000 lives worldwide.
The trial, which started in late May, tested the vaccine in 106 subjects aged 18 to 59 versus a placebo. The Phase I study looked at the vaccine’s safety and ability to induce immune responses. Headache, fatigue, and muscle pain were among the more common side effects, and the vaccine was “well tolerated” overall, the company said.
You can read about how the $NVAX vaccine works here in our article by TheSharedScope: COVID19 vaccines
higher?
Fk your rushed lower standard vaccine
Great
Awesome, in such a short time
But not T cell response like the Oxford one.
Go science
166 versions of cure; would be great if they all pool their resources I personally think that an injection will become a pre-req for a passport, reasonable insurance rates & entry into buildings & schools In addition, the injection will become a yearly healthy habit Cha-ching!
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Novavax Covid-19 Vaccine Produces Positive Results in First-Stage StudyNovavax said its experimental coronavirus vaccine induced promising immune responses and was generally well-tolerated in healthy adults in the first human study of the shot. Give everyone in Israel it since it's safe. The word 'generally' does not sound promising. 💪💪💪
Source: WSJ - 🏆 98. / 63 Read more »
Novavax's coronavirus vaccine generates promising immune response in early trial, data showsNovavax's potential vaccine to prevent Covid-19 generated a promising immune response in an early-stage clinical trial, the U.S.-based biotech firm announced Tuesday. Just make sure it's safe why then it dropped 25$ after hours?
Source: CNBC - 🏆 12. / 72 Read more »
Novavax coronavirus vaccine induces immune response in small studyMaryland-based biotechnology company Novavax said its experimental COVID-19 vaccine produced antibodies against the novel coronavirus and appears to be safe, according to an early stage study It stil has to go on trial fo another 3 mnths... Oh gosh how long shuld we wait or how pple shuld die bfre it's certain dat a 'Vaccine' is 💯 working Why does it sound so unreal, like I'm watching a bad movie...🤔🤔🤔 Spooky
Source: Reuters - 🏆 2. / 97 Read more »
Novavax Phase 1 data shows coronavirus vaccine is safe and elicits an immune responseA third US company has released study results showing its coronavirus vaccine is safe and elicits an immune response The trial shows vaccine ' may be a potential winner , but efficacy and safety studies need to continue ',one expert said. Fake fake news I love how so many “lockdown lunatics” have been screaming in panic for months that we must shutdown everything until we have a vaccine. But now they’re saying that they wouldn’t trust nor take any of these vaccines that are being developed. WTF is wrong with people...insanity.
Source: cnnbrk - 🏆 393. / 55 Read more »
Novavax stock: Human results for coronavirus vaccine candidate - Business InsiderBusiness Insider is a fast-growing business site with deep financial, media, tech, and other industry verticals. Launched in 2007, the site is now the largest business news site on the web. A friendly reminder: Phase I means absolutely nothing.
Source: BusinessInsider - 🏆 729. / 51 Read more »
As vaccines move into phase 3 trials, diversity must be at top of agendaEnsuring Black and ethnic minority participation in coronavirus vaccine trials is key if we want a truly effective coronavirus vaccine, according to experts. It's okay, race/ethnicity has nothing to do with biology I've been told. This sounds ridiculous and sensationalist. We're all human.. it's just a melanin thing.
Source: ABC - 🏆 471. / 51 Read more »